期刊名称：ANNALS OF ONCOLOGY
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Annals of Oncology is a multidisciplinary journal that publishes articles addressing medical oncology, surgery, radiotherapy, paediatric oncology, basic research and the comprehensive management of patients with malignant diseases.
Annals of Oncology is the official journal of the European Society for Medical Oncology.
Indexing
Annals Of Oncology is covered by the following major indexing services:
Abstracts on Hygiene and Communicable Diseases
CAB Abstracts
Current Contents® /Clinical Medicine
Elsevier BIOBASE - Current Awareness in Biological Sciences (CABS)
Derwent Drug File
EMBASE
Excerpta Medica Abstract Journals
Global Health
Helminthology Abstracts
Horticultural Abstracts
Journal Citation Reports /Science Edition
Nutrition Abstracts and Reviews
Nutrition Research Newsletter
Oncology information service
Pharmacoeconomics and Outcome News
Pharmacoeconomics and Outcome News
PROQUEST DATABASE : MEDLINE with Full Text
PROQUEST DATABASE : ProQuest 5000 International
PROQUEST DATABASE : ProQuest Central
PROQUEST DATABASE : ProQuest Health & Medical Complete
PROQUEST DATABASE : ProQuest Medical Library
Protozoological Abstracts
Prous Science Integrity®
PubMed
Reactions Weekly
Referativnyi Zhurnal
Review of Aromatic and Medicinal Plants
Review of Medical and Veterinary Mycology
Science Citation Index Expanded (SciSearch®)
Science Citation Index®
The Standard Periodical Directory
Tropical Diseases Bulletin
World Agricultural Economics and Rural Sociology Abstracts
Instructions to Authors
Editor-in-chief
Professor J B Vermorken, Oncology, Antwerp University Hospital, Wilrijkstraat 10, 2650 Edegem, Belgium
Aims and scope
Annals of Oncology publishes manuscripts that describe new findings of particular significance in any area related to clinical oncology and clinically oriented basic cancer research. The criteria for acceptance are originality and high scientific quality. Manuscripts should be submitted with a letter specifying that the report is not under consideration for publication elsewhere and that all named authors have agreed to its submission. Papers reporting clinical studies should, where appropriate, contain a statement that they have been carried out with ethics committee approval. Papers disregarding the welfare of experimental animals will be rejected. Studies should be carried out in accordance with the relevant national and local guidelines.
The editorial office will rapidly review the manuscripts in order that new findings may appear with minimum delay. The editorial office will return to authors within 3 weeks, whenever possible, all papers that are found to be of insufficient priority for further consideration. Papers of high interest will be sent out for external review. Authors will normally be notified of acceptance, rejection, or need for revision within 6 weeks of submission. Contributors will be provided with an electronic pdf proof via e-mail and corrections must be returned within two working days of receipt of the proof, by email or fax to +44-(0)1865-355-739. If this deadline is not met, the editorial office may take over the responsibility of proofreading.
Manuscript submission
Online submission
Once you have prepared your manuscript according to the instructions below please visit the online submission web site online submission web site. Instructions on submitting your manuscript online can be viewed here or via the online submission web site. Please check for an existing account before creating a new one, by entering your e-mail address in the “Password Help” field, and confirm it by clicking on the “GO” blue action box. You will then receive a message with your log-in details. In case your e-mail address has changed since the last time you accessed Annals of Oncology database, you can ask ScholarOne Helpdesk to send your log-in details to your new e-mail. To do so, you just have to select the orange link “Get Help Now” on the top-right of the page, and fill in your request.
Electronic files for text and figures should be prepared as described below. The file or files should be uploaded as directed.
Please contact the editorial office with any queries regarding submissions.
Language Editing
Particularly if English is not your first language, before submitting your manuscript you may wish to have it edited for language. This is not a mandatory step, but may help to ensure that the academic content of your paper is fully understood by journal editors and reviewers. Language editing does not guarantee that your manuscript will be accepted for publication. If you would like information about one such service please click here. There are other specialist language editing companies that offer similar services and you can also use any of these. Authors are liable for all costs associated with such services.
Ethics
When reporting experiments on human subjects, indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional or regional) or with the Helsinki Declaration (1964, amended in 1975, 1983, 1989, 1996 and 2000) of the World Medical Association. Do not use patients' names, initials, or hospital numbers, especially in any illustrative material. When reporting experiments on animals, indicate whether the institution's or the National Research Council's guide for, or any national law on, the care and use of laboratory animals was followed.
Manuscript presentation
The journal's language is English. British English or American English spelling and terminology may be used, but either one should be followed consistently throughout the article. Number the pages consecutively with the first page containing the following Headings:
- article type
- title
- author(s) list: first name(s) written with initials only, and followed by the last name - e.g. J. E. Smith (Note: in the on-line submission record you can enter a maximum number of 15 authors, however, manuscript files can have an unlimited number of authors.)
- affiliation(s) list: the affiliation list should be written as follows: Department/Division Name (in English), Affiliation/Institution, City, Country
- full address for correspondence, including department/division, telephone and fax number and e-mail address
Summary
Please provide a short summary of 200 words or less. The summary should not contain any undefined abbreviations or unspecified references. Summaries should be organized and formatted according to the following headings: (1) Background, (2) Patients and methods, (3) Results and (4) Conclusion(s). Authors may substitute 'Design' or 'Materials and methods' for 'Patients and methods' in summaries of Review articles or of papers dealing with basic research.
Key words
Please provide a maximum of six key words in alphabetical order, suitable for indexing.
Abbreviations
Abbreviations should be explained at first occurrence.
Decimal numerals
To enhance readability and clarity of the text as well as tables and figures, decimal numerals should - with the obvious exception of P-values - be rounded to the unit whenever possible (i.e. in all cases in which the rounding procedure does not change the meaning).
Article types
Annals of Oncology publishes material in the form of editorials, original articles, letters and reviews.
Editorials. Editorials are solicited by the editor and are generally related to a paper published in the same issue. Length and format of the editorial will be agreed upon between editor and author.
Original articles. Full articles should generally be no longer than 3000 words, excluding manuscript heading, abstract, references (which are unrestricted in number), acknowledgements, funding, tables and figures. In the case of Supplementary Material, please indicate if it can be published online only. If so, please upload it in separate file(s) (see Appendices section). There is no limit on the number of figures or tables. They must be prepared according to specific instructions (see below).
Letters to the editor. Letters are welcome and will be published if appropriate. They should be no longer than 500 words and a maximum of five references; one table or figure is acceptable if absolutely necessary. No abstract is required.
Reviews. Reviews are generally solicited by the editor, but unsolicited contributions will also be considered. These manuscripts summarize the state-of-the-art in a particular field. Reviews should generally be no longer than 4000 words, excluding manuscript heading, abstract, references (which are unrestricted in number), acknowledgements, funding, tables and figures. There is no limit on the number of figures or tables.
Clinical trials
Authors reporting clinical trials may find the guidelines given in the report of Simon and Wittes useful. (Simon R, Wittes RE. Methodologic guidelines for reports of clinical trials. Cancer Treat Rep 1985; 69: 1-3.) Particularly critical is the correct application and presentation of survival analyses: useful guidelines can be found in the appendix of the report by D. G. Altman et al. (Altman DG, De Stavola BL, Love SB, Stepniewska KA. Review of survival analyses published in cancer journals. Br J Cancer 1995; 72: 511-518).
The quality of data reporting on randomized clinical trials will be evaluated following the rules and checklist of the CONSORT statement (The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials. Moher D, Schulz KF, Altman DG et al. JAMA 2001; 285: 1987-1991); if required, material concerning this statement will be forwarded to the authors. Randomized clinical trials, which have begun after 1 January 1997, must be monitored and carried out in a manner permitting an absolute adherence to the rules of the CONSORT statement, as regards publication of their results. Potentially acceptable manuscripts will be submitted for statistical review.
Phase III trials
Phase III trials may be considered for fast track publication. Please contact the Editorial office.
Figures and tables
For preparation of figures for online submission and peer review please use the submission instructions in the 'Instructions and Forms' section of the web site.
Submission of electronic figures
Authors should supply the electronic versions of figures in either TIFF or Encapsulated PostScript (EPS) format, using PhotoShop compatible software. Many other formats, e.g. Microsoft Powerpoint, Microsoft Postscript and figures embedded in Word files, may be used, although this is not the preferred format.
Figures should be saved in separate files without their captions, which should be included with the text of the article
Editorial Board
Editor-in-Chief:
Professor D J Kerr
Department of Clinical Pharmacology
Radcliffe Infirmary
Woodstock Road
Oxford
OX2 6HE
Tel: 01865 224482
Fax: 01865 224538
www.clinpharm.ox.ac.uk
Associate Editors
M S Aapro, Genolier, Switzerland
J O Armitage, Omaha, Nebraska, USA
J Baselga, Barcelona, Spain
P Boyle, Milan, Italy
M Castiglione-Gertsch, Berne, Switzerland
B Coiffier, Pierre-Benite, France
R Labianca, Bergamo, Italy
T Le Chevalier, Villejuif, France
C J A Punt, Nijmegen, The Netherlands
N Thatcher, Manchester, UK
J B Vermorken, Edegem, Belgium
Editor Emeritus:
F Cavalli, Bellinzona, Switzerland
Editorial Board:
K Antman, New York, USA
J-P Armand, Villejuif, France
M Bendandi, Pamplona, Spain
M Björkholm, Stockholm, Sweden
C Bokemeyer, Tubingen, Germany
G Bonadonna, Milan, Italy
F Cabanillas, Houston, Texas, USA
C J Castro, Bogota, Columbia
A S Coates, Sydney, Australia
J M Connors, Vancouver, Canada
H Cortés-Funes, Madrid, Spain
V Diehl, Cologne, Germany
L H Einhorn, Indianapolis, Indiana, USA
E A Eisenhauer, Kingston, Canada
B Glimelius, Uppsala, Sweden
A Goldhirsch, Milan, Italy
H H Hansen, Copenhagen, Denmark
A L Harris, Oxford, UK
W Hiddemann, Munich, Germany
D Hossfeld, Hamburg, Germany
H Jürgens, Munster, Germany
S B Kaye, Sutton, UK
C-H Köhne, Dresden, Germany
P A Kosmidis, Athens, Greece
A S Lichter, Ann Arbor, MI, USA
A T Lister, London, UK
F Mandelli, Rome, Italy
G Masera, Monza, Italy
R J Mayer, Boston, Masachusetts, USA
F M Muggia, New York, USA
J P Neijt, Utrecht, The Netherlands
K Öberg, Uppsala, Sweden
S Pavlovsky, Buenos Aires, Argentina
M Pfreundschuh, Hamburg/Saar, Germany
M Piccart, Brussels, Belgium
H M Pinedo, Amsterdam, The Netherlands
V Raina, New Delhi, India
R Rosell, Badalona, Spain
A Roth, Geneva, Switzerland
E K Rowinsky, San Antonio, Texas, USA
N Saijo, Tokyo, Japan
H-J Schmoll, Halle, Germany
G Schwartsmann, Porto Alegre, Brazil
C N Sternberg, Rome, Italy
T Tursz, Villejuif, France
G Stoter, Rotterdam, The Netherlands
M Tonato, Perugia, Italy
E Van Cutsem, Leuven, Belgium
A T Van Oosterom, Leuven, Belgium
E E Vokes, Chicago, Illinois, USA
C Williams, Oxford, UK
J Zalcberg, Melbourne, Australia
Executive Editor
Lewis Rowett
Editorial Office:
Annals of Oncology
Via la Santa 7
CH-6962 Viganello-Lugano
Switzerland
Tel: +41 91 973 1910
Fax: +41 91 973 1909
E-mail: annonco@oncogroup.ch
|
